Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis
Authors:
- Fran Cook-BoldenFCFran Cook-Bolden
- Jeffrey M. WeinbergJWJeffrey M. Weinberg
- 1 January 2002
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 46 (1) , 146-147
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001
- Bowen's Disease (Squamous Cell Carcinoma In Situ) in Immunosuppressed Patients Treated with Imiquimod 5% Cream and a COX Inhibitor, Sulindac: Potential Applications for This Combination of ImmunotherapyDermatologic Surgery, 2001
- Imiquimod and 5% Fluorouracil Therapy for Anal and Perianal SquamousCell Carcinoma In Situ in an HIV-1–Positive ManArchives of Dermatology, 2001
- The Use of Imiquimod 5% Cream for the Treatment of Superficial Basal Cell Carcinomas in a Basal Cell Nevus Syndrome PatientDermatologic Surgery, 2000
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999